Thomas Damgaard Sandahl

Genetisk HFE-hæmokromatose

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Genetisk HFE-hæmokromatose. / Milman, Nils T; Schiødt, Frank V; Junker, Anders E; Magnussen, Karin; Nathan, Torben; Sandahl, Thomas Damgaard.

In: Ugeskrift for Laeger, Vol. 180, No. 51, V09180619, 17.12.2018.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Milman, NT, Schiødt, FV, Junker, AE, Magnussen, K, Nathan, T & Sandahl, TD 2018, 'Genetisk HFE-hæmokromatose', Ugeskrift for Laeger, vol. 180, no. 51, V09180619.

APA

Milman, N. T., Schiødt, F. V., Junker, A. E., Magnussen, K., Nathan, T., & Sandahl, T. D. (2018). Genetisk HFE-hæmokromatose. Ugeskrift for Laeger, 180(51), [V09180619].

CBE

Milman NT, Schiødt FV, Junker AE, Magnussen K, Nathan T, Sandahl TD. 2018. Genetisk HFE-hæmokromatose. Ugeskrift for Laeger. 180(51):Article V09180619.

MLA

Milman, Nils T et al. "Genetisk HFE-hæmokromatose". Ugeskrift for Laeger. 2018. 180(51).

Vancouver

Milman NT, Schiødt FV, Junker AE, Magnussen K, Nathan T, Sandahl TD. Genetisk HFE-hæmokromatose. Ugeskrift for Laeger. 2018 Dec 17;180(51). V09180619.

Author

Milman, Nils T ; Schiødt, Frank V ; Junker, Anders E ; Magnussen, Karin ; Nathan, Torben ; Sandahl, Thomas Damgaard. / Genetisk HFE-hæmokromatose. In: Ugeskrift for Laeger. 2018 ; Vol. 180, No. 51.

Bibtex

@article{c77d7412192442fd8593b4aa06441883,
title = "Genetisk HFE-h{\ae}mokromatose",
abstract = "HFE-haemochromatosis is the most frequent genetic disposition for iron overload in ethnic Danes: 20,000 persons are homozygous for the C282Y mutation. The disorder has a long preclinical phase with increasing body iron overload, and 30% of males will develop clinically overt disease, presenting with symptoms of fatigue, arthralgias, reduced libido, erectile dysfunction, cardiac disease, diabetes and liver disease, later progressing into cirrhosis, cardio-myo-pathy, pancreatic fibrosis and osteoporosis. Treatment consists of phlebotomies, which in the preclinical and early clinical phases ensure normal survival.",
author = "Milman, {Nils T} and Schi{\o}dt, {Frank V} and Junker, {Anders E} and Karin Magnussen and Torben Nathan and Sandahl, {Thomas Damgaard}",
year = "2018",
month = dec,
day = "17",
language = "Dansk",
volume = "180",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Den Almindelige Danske L{\ae}geforening",
number = "51",

}

RIS

TY - JOUR

T1 - Genetisk HFE-hæmokromatose

AU - Milman, Nils T

AU - Schiødt, Frank V

AU - Junker, Anders E

AU - Magnussen, Karin

AU - Nathan, Torben

AU - Sandahl, Thomas Damgaard

PY - 2018/12/17

Y1 - 2018/12/17

N2 - HFE-haemochromatosis is the most frequent genetic disposition for iron overload in ethnic Danes: 20,000 persons are homozygous for the C282Y mutation. The disorder has a long preclinical phase with increasing body iron overload, and 30% of males will develop clinically overt disease, presenting with symptoms of fatigue, arthralgias, reduced libido, erectile dysfunction, cardiac disease, diabetes and liver disease, later progressing into cirrhosis, cardio-myo-pathy, pancreatic fibrosis and osteoporosis. Treatment consists of phlebotomies, which in the preclinical and early clinical phases ensure normal survival.

AB - HFE-haemochromatosis is the most frequent genetic disposition for iron overload in ethnic Danes: 20,000 persons are homozygous for the C282Y mutation. The disorder has a long preclinical phase with increasing body iron overload, and 30% of males will develop clinically overt disease, presenting with symptoms of fatigue, arthralgias, reduced libido, erectile dysfunction, cardiac disease, diabetes and liver disease, later progressing into cirrhosis, cardio-myo-pathy, pancreatic fibrosis and osteoporosis. Treatment consists of phlebotomies, which in the preclinical and early clinical phases ensure normal survival.

M3 - Tidsskriftartikel

C2 - 30618363

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 51

M1 - V09180619

ER -